In Defense of Baseline Genotypic Antiretroviral Resistance Testing
J Acquir Immune Defic Syndr
.
2020 Jan 1;83(1):e1-e2.
doi: 10.1097/QAI.0000000000002210.
Authors
Raynell Lang
1
,
Hartmut B Krentz
2
,
M John Gill
3
Affiliations
1
Department of Medicine, University of Calgary, Calgary, Canada.
2
S Alberta HIV Clinic Calgary, Calgary, Canada.
3
Department of Medicine, University of Calgary, S Alberta HIV Clinic Calgary, Calgary, Canada.
PMID:
31809365
DOI:
10.1097/QAI.0000000000002210
No abstract available
Publication types
Letter
MeSH terms
Anti-HIV Agents / therapeutic use*
Drug Resistance, Viral / genetics*
Genotype*
HIV / drug effects*
HIV / genetics
HIV Infections / drug therapy
HIV Infections / virology
Humans
Substances
Anti-HIV Agents